EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin ...
EUDA Health Holdings Limited (EUDA) is positioned as a healthcare-technology company providing non-invasive healthcare services and digital healthcare capabilities, with operations focused largely in Singapore and other parts of Asia, including Malaysia and China. The company’s stated purpose and market positioning emphasize improving access to healthcare through technology—particularly by facilitating ...EUDA Health Holdings Limited (EUDA) is positioned as a healthcare-technology company providing non-invasive healthcare services and digital healthcare capabilities, with operations focused largely in Singapore and other parts of Asia, including Malaysia and China. The company’s stated purpose and market positioning emphasize improving access to healthcare through technology—particularly by facilitating online medical consultations for routine, non-urgent health concerns.
From a business and operating perspective, EUDA’s model blends (1) medical services delivered through an organized service platform and (2) technology-driven engagement and consultation workflows. This combination typically means the company must coordinate clinical/medical delivery (e.g., qualified healthcare professionals), customer-facing experience (e.g., user onboarding, symptom/health history intake, consultation booking), and supporting back-office systems (e.g., scheduling, documentation, billing, and compliance). The company’s focus on “routine, non-urgent” care suggests an emphasis on scalable, standardized consultation pathways rather than high-acuity hospital services.
Product and services scope is described in the sources as an innovative platform enabling online medical consultations and a broader Southeast Asian digital healthcare ecosystem. Such ecosystems generally include patient interaction, clinical triage/consultation, and potentially downstream healthcare management activities (depending on regional regulatory frameworks). EUDA’s market footprint—Singapore, Malaysia, and China—also implies it must adapt service delivery and operational processes to local healthcare rules and partner networks.
In terms of costs and cost drivers (BOM and operating cost structure at a practical level), digital healthcare platforms usually incur recurring technology and personnel costs (software/platform maintenance, cybersecurity, data systems, customer support) alongside clinical operations costs (medical staff, consultation workflows, quality assurance). The company also needs distribution and compliance overheads across jurisdictions. The provided financial snapshot shows profitability pressure at the trailing-twelve-month level (negative operating margins and net profit margin), which is consistent with early-stage scaling, investment in operations/technology, or higher fixed costs relative to revenue.
The dataset indicates revenue-related profitability metrics such as gross profit margin around the high 40% range, while operating and net margins are negative (e.g., operating profit margin and net profit margin shown as negative). It also shows liquidity/working-capital stress signals (e.g., current ratio and working capital figures in the dataset), which can matter for a company balancing growth investments and operating needs.
Key people disclosed in the sources include CEO Alfred Lim (and board-level references to Dr. Kelvin Chen as Chief Executive Officer in some materials). EUDA’s leadership and governance structure therefore appears to include a board with independent directors alongside executive leadership.
Overall, EUDA aims to deliver accessible, tech-enabled non-invasive healthcare services across Southeast Asia and adjacent markets, targeting segments that benefit from convenient online consultations. Its near-term “wishes” as implied by the market narrative are likely centered on scaling service adoption, improving unit economics, and sustaining compliance-ready operations while continuing to develop and operationalize its digital healthcare ecosystem.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$6.8M
+70.0%
+262.5%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-2.8M
+81.9%
-253.5%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+43.9%
+130.9%
-23.5%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-35.8%
+91.7%
-1.6%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
-40.7%
+89.4%
+2.5%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-2.5M
-17.7%
-295.8%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
-37.1%
+30.8%
-9.2%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
-56.4%
-13.2%
+0.0%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
0.18x
-3.3%
0.0%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
